The relationship between biologically and immunologically active luteinizing hormone (LH) in plasma was investigated daily throughout a menstrual cycle in 29 women before and during the second month of the oral administration of norethisterone (Mini-Pe\s=r\,Astra-Syntex) in a daily dose of 0.3 mg. The biological activity was determined by an in vitro bioassay and the immunological activity by a radioimmunoassay method. A characteristic midcycle surge of LH was observed with both assay methods in all 29 control cycles. Of the 29 treatment cycles studied with both assay methods, 10 cycles exhibited a similar LH pattern, although the levels of both activities were significantly depressed (P < 0.001) during all phases of the cycle. The biological to immunological (B/I) ratios of plasma LH between the treatment and control cycles were not significantly different. Of the remaining 19 treatment cycles, in which no "midcycle" LH peak was evidenced, the levels of both activities in the treatment periods were significantly lower (P < 0.05) than in the follicular phase and significantly higher than in the luteal phase (P < 0.05) of the control cycles. The overall B/I ratios were significantly lower in the treatment periods than in the control cycles (P < 0.001). However, the influence of this difference on the general pattern of immunological activity in comparison with that of biological activity was relatively small. It is concluded that the irregular patterns of immunological hLH activity which are observed after treatment with low doses of norethisterone are similar to those of the biological activity.
The continuous administration to normally menstruating women of oral con¬ traceptives containing microdoses of progestogens frequently results in ab¬ normal plasma and urinary patterns of LH activity throughout the menstrual cycle, sometimes in contrast to the seemingly normal patterns of plasma oestradiol and progesterone (for reviews consult Population Reports (1975) . Moghissi (1976) and Fotherby (1977) ).
In a recently completed large scale study, in which plasma levels of im¬ munoreactive LH, oestradiol and progesterone were analysed daily in 43 women throughout a control cycle and then during the second month of the daily oral administration of 300 fig of norethisterone, an unexpected dichotomy was frequently observed between the profile of the plasma levels of LH, on the one hand, and the levels of oestradiol and progesterone, on the other hand (Landgren et al., in press ). In some cases a marked LH surge was observed in the absence of any rise in progesterone levels (Landgren 8c Diczfalusy 1978), whereas in other cases the lack of any midcycle surge of LH was associated with normal "ovulatory" profiles of progesterone, 17-hydroxyprogesterone, 20«-dihydroprogesterone and oestradiol The 29 healthy women who volunteered for the study were part of a larger group studied in an investigation of the pharmacodynamic effects of NET, the details of which are to be reported elsewhere (Landgren et al., in press). These 29 women were in the fertile age (mean age 29 years, range 19 to 39 years) with a history of regular cycles and exhibiting normal haemoglobin values. The criteria used to define these cycles as normal have been previously described (Guerrero et al. 1976 : Aedo et al. 1976 ).
Blood was collected daily throughout the control cycles from all 29 women and from, the same women for one cycle during the second month of the administration of the "minipill" (300 tig NET/day orally). In addition, blood was collected daily through¬ out the sixth treatment cycle from 5 of the 29 subjects. The (Robertson et al. ¡978). The within-assay variation as assessed by the coef¬ ficient of variation of duplicate measurements from 400 estimates was 4.6 "In. The between-assay variation as assessed on the basis of the reproducibility of the potency of a plasma pool, assayed concurrently with the unknowns, was 3.8°/o (n = 26).
Radioimmunoassay (RIA) procedure.
An hLH-RIA procedure using the Kabi hLH kit (Kabi Diagnostica, Stockholm) was used. Non-equilibrium assay conditions were employed with the 69/Ì04 preparation as standard. Further details of the assay are presented elsewhere (Robertson 8~D iczfalusy ¡977). The immunoactivity in the plasma samples was determined at one dose level against a linearized standard response line.
The 68/40 preparation, while it is the officially recommended and by now preferred standard preparation for the radioimmunoassay of hLH in this laboratory, could not be employed in this assay system'), since the logit log-dose response line was non-linear over the whole working range (Robertson 8c Diczfalusy 1977 significant differences were observed between treatment and the corresponding control cycles, neither with respect to the geometric mean (daily) B/I ratio for each cycle nor with regard to the regression coefficients.
D ISCUSSION
There is a high degree of similarity between the profiles of biologically and immunologically active hLH in plasma of women after treatment with NET. The differences that are observed between the treatment and control periods, although statistically significant, would seem to be rather limited. These dif¬ ferences, which were noted in the group in which no discernible LH peak was observed during the treatment periods (Group II), were attributed to the higher levels of immunologically active, biologically inactive material compared to those in the corresponding control cycles. This conclusion was based on the differences between the treatment and control cycles in the intercept values of the regression line obtained from the regression analysis of the two activities. In support, significant differences in the B/I ratios were obtained for samples chosen from throughout the treatment and control cycles with the lowest biological activity. These differences might be attributed to the higher plasma levels of biologically-inactive immunologically-active material (e.g. LH subunits) in the treatment cycles than in the corresponding control cycles. Additonal studies involving the fractionation of the biological and immunological activities of plasma into their individual components will be needed to resolve the nature of this material.
The elevated B/I ratios (i.e. greater than unity) observed in this study can, to a large extent, be accounted for by the reagents employed in the RIA, Studies conducted concurrently with the present investigation have shown that such elevated B/I ratios are due to the purity of the LH preparation used as standard (Robertson 8c Diczfalusy 1977) as well as to the presence of iodinated subunits in the iodinated LH preparation used as tracer in the RIA, and to the specificity of the antiserum employed (Suginami et al. 1978) .
In the present study, which was conducted in [1976] [1977] 
